John is a writer at Pocket-lint. He is passionate about all things technology, and is always keeping up with the latest smartphone and PC releases. John has previously written at MobileSyrup. When ...

Remembering the quirky and at times short-lived formats for securing our digital photographs and video, exploring what they offered and why they failed When you purchase through links on our site, we ...

This buy brings the Resideo Technologies stake to 88.4% of 13F reportable AUM as of Dec. 31, 2025. Top holdings after the filing: Resideo Technologies: $525.96 million (88.4% of AUM) Agilon Health: ...

We are The People's Media. USA Herald covers everything from breaking news to investigative journalism. We also report on politics on the State and National level ...

Covetrus, a private-equity-backed tech company for veterinary practices, is in preliminary talks to purchase Cencora Inc.'s veterinary business, according to a Bloomberg report from late Friday. CD&R, ...

Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at least $2.5 billion of debt for Covetrus, a technology company for veterinary ...

You're probably familiar with the vinyl resurgence. The trend, which has been happening for years now, sees a new generation becoming acquainted with vinyl records, as well as record players or ...

These days, it has become very easy to watch your favorite movies and listen to top songs anytime, anywhere you want. There are music streaming platforms like Spotify where you can listen to your ...

CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...

PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & ...

Oct 10 (Reuters) - Sanofi (SASY.PA), opens new tab is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & ...